ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro.
Eichenauer DA, Simhadri VL, von Strandmann EP, Ludwig A, Matthews V, Reiners KS, von Tresckow B, Saftig P, Rose-John S, Engert A, Hansen HP.
Eichenauer DA, et al. Among authors: von tresckow b, von strandmann ep.
Cancer Res. 2007 Jan 1;67(1):332-8. doi: 10.1158/0008-5472.CAN-06-2470.
Cancer Res. 2007.
PMID: 17210715